The anti-cancer effects of SHK (Fig. 1a) were first evaluated by treating colorectal cancer cells with various concentrations of SHK (0 μM, 0.5 μM, 1 μM, 2 μM, and 5 μM). The gene discussed is SHPK; the disease is cancer.